Platform/Neurology

Acrigen Biosciences

Developing best-in-class precision gene editing platforms to improve the safety and efficacy of CRISPR therapeutics.

Red Tree Participation
Led seed round

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Board Observer

Jennifer Cochran, Ph.D.

Total Addressable Market

$10 billion+

Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Board Observer

Jennifer Cochran, Ph.D.

Red Tree Participation
Led seed round

Acrigen Biosciences

Platform/Neurology
Total Addressable Market

$10 billion+

Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Board Observer

Jennifer Cochran, Ph.D.

Red Tree Participation
Led seed round